Mykola Nikolaiev, CEO of Oximio, Olga Vizgalova, Regional Director for Central Eastern Europe and Dmytro Zavada, KAM Team Leader will be attending the Cell and Gene Therapy International Europe conference.
Cell and Gene Therapy International is Europe’s must‑attend conference for anyone working at the forefront of cell and gene therapy development — from research and development, manufacturing and analytics, to clinical, regulatory and investment.
The conference is a chance to explore key areas such as cold chain logistics for sensitive therapies, global sourcing of medicines and equipment, clinical trial logistics including warehousing and distribution, and patient-centric solutions such as direct-to-patient delivery and home nursing support. It is also a great platform to see what is new in advanced therapies, compare different approaches, and learn how the industry is being transformed across Europe.
If you will be attending, please contact us to arrange a meeting. We would love to talk about how Oximio can support your cell and gene therapy development efforts — whether that is with clinical trial supply, specialised logistics, compliance, or other ways we can help bring your innovation closer to patients.